Herbert Cross
Director of Finance/CFO en JASPER THERAPEUTICS, INC. .
Fortuna: 5 825 $ al 31/03/2024
Perfil
Herbert C.
Cross is currently the Director at DNAtrix, Inc., Independent Director at Apexigen America, Inc., and Secretary, Chief Financial & Accounting Officer at Jasper Therapeutics, Inc. He previously served as the Independent Director at Apexigen, Inc. from 2019 to 2023, Vice President-Finance at Neoforma, Inc. from 2001 to 2007, Chief Executive & Financial Officer at Humanigen, Inc. in 2015, Principal Accounting Officer & Controller at Abbott Biotherapeutics Corp.
from 2008 to 2014, Chief Financial Officer at Atreca, Inc. from 2019 to 2023, Chief Financial Officer at Affymax, Inc. from 2011 to 2013, Manager-Assurance & Business Advisory Services at Arthur Andersen LLP from 1994 to 1999, Chief Accounting Officer at PDL BioPharma, Inc. from 2006 to 2009, CFO & Principal Accounting Officer at ARMO BioSciences, Inc. in 2017, and Chief Financial Officer at Balance Therapeutics, Inc. in 2016-2017.
He received his undergraduate degree from Haas School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ATRECA, INC. CLASS A
0.19% | 02/08/2023 | 72 817 ( 0.19% ) | 5 825 $ | 31/03/2024 |
| 15/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Herbert Cross
| Empresas | Cargo | Inicio |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Director of Finance/CFO | 22/09/2023 |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Director/Board Member | 18/02/2021 |
Antiguos cargos conocidos de Herbert Cross.
| Empresas | Cargo | Fin |
|---|---|---|
| ATRECA, INC. | Director of Finance/CFO | 22/09/2023 |
| APEXIGEN, INC. | Director/Board Member | 23/08/2023 |
| ARMO BIOSCIENCES INC | Director of Finance/CFO | 21/06/2018 |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Director of Finance/CFO | 01/11/2017 |
| HUMANIGEN, INC. | Chief Executive Officer | 20/11/2015 |
Formación de Herbert Cross.
| Haas School of Business | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| ATRECA, INC. | Health Technology |
| AFFYMAX, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
| Empresas privadas | 7 |
|---|---|
Neoforma, Inc.
 Neoforma, Inc. Medical DistributorsDistribution Services Neoforma, Inc. provides e-commerce services to healthcare industry. It also provides supply chain management solutions between hospitals and suppliers. The Company was founded in 1996 and is located in SanJose, CA. | Distribution Services |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Herbert Cross
